Daniel Clark
Stock Analyst at Leerink Partners
(2.79)
# 1,691
Out of 5,129 analysts
7
Total ratings
80%
Success rate
30.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $646.53 | -7.20% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $128.13 | +20.97% | 2 | Jul 17, 2025 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $18 | $25.61 | -29.71% | 2 | Jul 17, 2025 |
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $646.53
Upside: -7.20%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $128.13
Upside: +20.97%
Elanco Animal Health
Jul 17, 2025
Upgrades: Outperform
Price Target: $18
Current: $25.61
Upside: -29.71%